This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chen, Z. Y. Articles by Tseng, C.-C. Search for Related Content PubMed PubMed Citation Articles by Chen, Z. Y. Articles by Tseng, C.-C.

Destabilization of Krüppel-Like Factor 4 Protein in Response to Serum Stimulation Involves the Ubiquitin-Proteasome Pathway

Section of Gastroenterology, VA Boston Healthcare System and Boston University School of Medicine, Boston, Massachusetts

Requests for reprints: Zhi Yi Chen, Section of Gastroenterology, Boston University School of Medicine, EBRC X-513, 650 Albany Street, Boston, MA 02118. Phone: 617-638-6524; Fax: 617-638-7785; E-mail: zhiyi.chen{at}bmc.org.

Although the zinc finger transcription factor Krüppel-like factor 4 (KLF4) has been shown to be a negative regulator of cell proliferation, the mechanisms underlying the posttranslational modification of KLF4, especially at the level of protein degradation, are poorly understood. Here, we show that KLF4 protein levels in quiescent cells were high, but decreased rapidly as cells entered the proliferating stage following serum stimulation. This decrease was partially reversed by pretreatment with MG132, a proteasome inhibitor. Moreover, KLF4 was an unstable protein that underwent rapid turnover, and exhibited a relatively short half-life (t_1/2 120 minutes). To investigate the involvement of the ubiquitin-proteasome pathway in the regulation of the stability of KLF4, HCT116 cells were treated with proteasome inhibitors. Our results showed that, following lactacystin treatment, levels of endogenous KLF4 increased in a time- and dose-dependent manners. Using a cell-free system, in vitro–translated ³⁵S-labeled KLF4 protein was degraded by protein extracts prepared from exponentially growing HCT116 cells in the presence of ATP. These effects were prevented by pretreatment with MG132 or replacement of ATP with ATP--S, a nonhydrolyzable analogue of ATP, suggesting that ATP is required for KLF4 degradation by the 26S proteasome. In addition, KLF4 was subject to ubiquitination when cells were treated with the proteasome inhibitor or transfected with exogenous ubiquitin. Collectively, these results indicate that destabilization of KLF4 following serum stimulation is mediated, at least in part, through a ubiquitin-proteasome pathway.

This article has been cited by other articles:

				D. Wei, M. Kanai, Z. Jia, X. Le, and K. Xie Kruppel-like Factor 4 Induces p27Kip1 Expression in and Suppresses the Growth and Metastasis of Human Pancreatic Cancer Cells Cancer Res., June 15, 2008; 68(12): 4631 - 4639. [Abstract] [Full Text] [PDF]

				J. K. Alder, R. W. Georgantas III, R. L. Hildreth, I. M. Kaplan, S. Morisot, X. Yu, M. McDevitt, and C. I. Civin Kruppel-Like Factor 4 Is Essential for Inflammatory Monocyte Differentiation In Vivo J. Immunol., April 15, 2008; 180(8): 5645 - 5652. [Abstract] [Full Text] [PDF]

				W. Ai, H. Zheng, X. Yang, Y. Liu, and T. C. Wang Tip60 functions as a potential corepressor of KLF4 in regulation of HDC promoter activity Nucleic Acids Res., September 25, 2007; 35(18): 6137 - 6149. [Abstract] [Full Text] [PDF]

				M. Kanai, D. Wei, Q. Li, Z. Jia, J. Ajani, X. Le, J. Yao, and K. Xie Loss of kruppel-like factor 4 expression contributes to sp1 overexpression and human gastric cancer development and progression. Clin. Cancer Res., November 1, 2006; 12(21): 6395 - 6402. [Abstract] [Full Text] [PDF]